Arch Therapeutics, Inc.

ARTH · OTC
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$6-$1-$3-$2
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$2-$0
Stock-Based Comp.$0-$0$0$0
Change in WC$0$0$1$0
Other Non-Cash$4$0-$1$1
Operating Cash Flow-$1-$1-$1-$1
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.$2$0$0$0
Stock Issued$0$0$0$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$1$1$1
Financing Cash Flow$1$1$1$1
Forex Effect$0$0$0$0
Net Chg. in Cash$0-$0-$0$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$0$0$0$0
Free Cash Flow-$1-$1-$1-$1